Syngene International Intrinsic Value
Syngene International (SYNGENE) median intrinsic value is ₹230.20 from 9 valuation models (range ₹138–₹374), vs current price ₹460.40 — -50.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit SYNGENE share price.
SYNGENE Valuation Methods Summary — DCF, Graham Number & P/E
Syngene International intrinsic value across 9 models vs current price ₹460.40 — upside/downside and value range per method. Also explore Syngene International stock price data download to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹323.84 | ₹259.07 - ₹388.61 | -29.7% | EPS: ₹14.72, Sector P/E: 22x |
| Book Value Method | asset | ₹240.15 | ₹216.14 - ₹264.17 | -47.8% | Book Value/Share: ₹120.07, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹210.22 | ₹189.20 - ₹231.24 | -54.3% | Revenue/Share: ₹105.11, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹317.62 | ₹285.86 - ₹349.38 | -31.0% | EBITDA: ₹1280.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹373.89 | ₹299.11 - ₹448.67 | -18.8% | CF Growth: 13.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹138.12 | ₹124.31 - ₹151.93 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹227.42 | ₹204.68 - ₹250.16 | -50.6% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹230.20 | ₹207.18 - ₹253.22 | -50.0% | ROE: 12.2%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹199.42 | ₹179.48 - ₹219.36 | -56.7% | EPS: ₹14.72, BVPS: ₹120.07 |
SYNGENE Intrinsic Value vs Market Price — All Valuation Models
Syngene International fair value range ₹138–₹374 vs current market price ₹460.40 across 9 valuation models. Browse SYNGENE annual financials for revenue, profit, balance sheet and cash flow data.
SYNGENE Intrinsic Value Analysis — Undervalued or Overvalued?
Syngene International median intrinsic value ₹230.20, current price ₹460.40 — Trading Above Calculated Value by 50.0%, margin of safety -100.0%.
What is the intrinsic value of SYNGENE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Syngene International (SYNGENE) is ₹230.20 (median value). With the current market price of ₹460.40, this represents a -50.0% variance from our estimated fair value.
The valuation range spans from ₹138.12 to ₹373.89, indicating ₹138.12 - ₹373.89.
Is SYNGENE undervalued or overvalued?
Based on our multi-method analysis, Syngene International (SYNGENE) appears to be trading above calculated value by approximately 50.0%.
SYNGENE Financial Health — Key Ratios vs Industry Benchmarks
Syngene International financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.23 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.2% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.60x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SYNGENE Cash Flow Quality — Operating & Free Cash Flow
Syngene International operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,168 Cr | ₹796 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,042 Cr | ₹795 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹824 Cr | ₹498 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹581 Cr | ₹276 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹701 Cr | ₹387 Cr | Positive Free Cash Flow | 8/10 |